Lakewood Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.6M | Buy |
202,150
+12,000
| +6% | +$4.67M | 5.87% | 4 |
|
|
2025
Q1 | $82.7M | Buy |
190,150
+11,500
| +6% | +$5M | 7.21% | 2 |
|
|
2024
Q4 | $65.9M | Buy |
178,650
+79,150
| +80% | +$29.2M | 5.91% | 2 |
|
|
2024
Q3 | $51.7M | Buy |
99,500
+16,500
| +20% | +$8.58M | 4.07% | 9 |
|
|
2024
Q2 | $45M | Buy |
83,000
+5,000
| +6% | +$2.71M | 3.67% | 11 |
|
|
2024
Q1 | $40.4M | Buy |
78,000
+16,000
| +26% | +$8.3M | 3.3% | 12 |
|
|
2023
Q4 | $29.2M | Hold |
62,000
| – | – | 2.45% | 15 |
|
|
2023
Q3 | $27M | Buy |
62,000
+2,000
| +3% | +$871K | 2.46% | 15 |
|
|
2023
Q2 | $26.7M | Buy |
+60,000
| New | +$26.7M | 2.31% | 16 |
|
|
2022
Q1 | – | Sell |
-80,939
| Closed | -$37.5M | – | 55 |
|
|
2021
Q4 | $37.5M | Hold |
80,939
| – | – | 1.59% | 25 |
|
|
2021
Q3 | $30.2M | Sell |
80,939
-32,000
| -28% | -$11.9M | 1.33% | 27 |
|
|
2021
Q2 | $43.1M | Sell |
112,939
-121,500
| -52% | -$46.4M | 1.78% | 24 |
|
|
2021
Q1 | $84.2M | Buy |
234,439
+13,000
| +6% | +$4.67M | 3.57% | 9 |
|
|
2020
Q4 | $71.1M | Sell |
221,439
-59,000
| -21% | -$18.9M | 3.33% | 11 |
|
|
2020
Q3 | $75.3M | Buy |
280,439
+32,700
| +13% | +$8.78M | 3.63% | 7 |
|
|
2020
Q2 | $65.2M | Buy |
247,739
+62,300
| +34% | +$16.4M | 2.8% | 13 |
|
|
2020
Q1 | $42.1M | Buy |
185,439
+439
| +0.2% | +$99.7K | 1.93% | 20 |
|
|
2019
Q4 | $55.9M | Buy |
+185,000
| New | +$55.9M | 1.98% | 18 |
|